Skip to main content
OpenTrials
Completed

NCT Number: NCT07421271

Evaluation of the Method and Duration of Urinary Diversion in the Management of Distal Penile Hypospadias Following Surgical Repair.

This study aims to conduct a head-to-head comparison to determine the optimal method and duration of urinary diversion following distal penile hypospadias repair. Specifically, it will evaluate whether urethral diversion alone or a combination of urethral and suprapubic diversions provides better outcomes, and whether a postoperative duration of one week or two weeks is more effective.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypospadias Congenital Abnormalities Congenital, Hereditary, and Neonatal Diseases and Abnormalities Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Male Male Urogenital Diseases Penile Diseases Urinary Diversion Urogenital Abnormalities Urogenital Diseases

Age range

6 month–18 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Ain shams university

Cairo, 11517, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with Distal Hypospadias (Glanular, Coronal, Subcoronal)
  • Patients have Adequate ventral penile skin mobility

Exclusion criteria

  • Patients with Crippled hypospadias.
  • Patients with Proximal hypospadias.
  • Patients with Hypoplastic urethra.
  • Patients with Neurogenic bladder

Treatment and study plan

Application of urethral catheter alone for 1 week.

Procedure

Application of urethral catheter alone for 1 week.

Application of urethral catheter alone for 2 weeks.

Procedure

Application of urethral catheter alone for 2 weeks.

Application of urethral stent and suprapubic catheter for 1 week

Procedure

Application of urethral stent and suprapubic catheter for 1 week

Application of urethral stent and suprapubic catheter for 2 weeks

Procedure

Application of urethral stent and suprapubic catheter for 2 weeks

Primary outcomes

  1. Decreased rate of fistula occurrence

    Time frame: 1 month

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Feb 19, 2026
Registry last updated
Feb 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.